ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A
The purpose of this study is to study the evaluation of efficacy and safety of GreenGene (Recombinant Factor VIII).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study#979454
- The effect of F8 missense variants on desmopressin response in people with nonsevere hemophilia A investigated using machine learning.#1080548
- Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001#1044529
- Thrombosis in Diffuse Large B-cell Lymphoma:the PREDIC-TO (PREDICt ThrOmbosis) Study#992172
- Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B#871747
Record · ID 859047
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive